Search results
Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
Benzinga via AOL· 6 days agoThis global collaboration combines the strengths of both Chiesi and Gossamer to support ongoing work...
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
AOL· 6 days agoThe therapy is currently in late-stage development for the treatment of pulmonary arterial hypertension (PAH), which affects about 40,000 people in the ...
Gossamer Bio and Chiesi partner for pulmonary hypertension treatment
Pharmaceutical Technology via Yahoo Finance· 5 days agoGossamer co-founder, chairman and CEO Faheem Hasnain stated: “This partnership with Chiesi allows us...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoNeurocrine stock is an IBD Tech Leader. Focusing On Treatments For PAH United Therapeutics is now a...
Linda Evangelista attends Met Gala for the first time in nearly a decade
Page Six· 5 days agoThe ’90s supermodel last attended the star-studded soirée in 2015 —- the same year she started...
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Zacks· 2 days agoInsmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
Chiesi buys into Gossamer’s Winrevair rival, betting almost $500M
FierceBiotech· 6 days agoItalian pharma Chiesi is betting almost $500 million on Gossamer Bio's pulmonary arterial...
Gossamer sells rights to drug it hopes can rival a new Merck therapy
BioPharma Dive via Yahoo Finance· 6 days agoOne analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing...
Liquidia (LQDA) Scheduled to Post Earnings on Tuesday
ETF DAILY NEWS· 10 hours agoLiquidia (NASDAQ:LQDA – Get Free Report) will post its quarterly earnings results before the market opens on Tuesday, May 14th. Analysts expect the company to announce earnings of ($0.32) per ...
3 Biotech Stocks to Double Your Money in the Next 24 Months
InvestorPlace· 6 days agoThe biotechnology sector is renowned for its potential to deliver groundbreaking medical treatments...
